Healthcare provider profile · identity verified

Bernice Francesca Lim, MD

Family Practice · LORIS, SC · NPI 1326303538

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	436	139
Gabapentin	Gabapentin	309	87
Amlodipine Besylate	Amlodipine Besylate	287	106
Lisinopril	Lisinopril	280	88
Losartan Potassium	Losartan Potassium	241	79
Albuterol Sulfate Hfa	Albuterol Sulfate	199	75
Levothyroxine Sodium	Levothyroxine Sodium	156	47
Metformin Hcl	Metformin Hcl	143	44
Metoprolol Tartrate	Metoprolol Tartrate	143	48
Tramadol Hcl	Tramadol Hcl	140	42
Omeprazole	Omeprazole	129	47
Pantoprazole Sodium	Pantoprazole Sodium	121	43
Hydrochlorothiazide	Hydrochlorothiazide	120	37
Hydralazine Hcl	Hydralazine Hcl	116	31
Ozempic	Semaglutide	110	23
Trazodone Hcl	Trazodone Hcl	110	35
Rosuvastatin Calcium	Rosuvastatin Calcium	102	35
Januvia	Sitagliptin Phosphate	99	35
Montelukast Sodium	Montelukast Sodium	96	28
Duloxetine Hcl	Duloxetine Hcl	84	19
Tamsulosin Hcl	Tamsulosin Hcl	73	23
Glimepiride	Glimepiride	72	23
Metoprolol Succinate	Metoprolol Succinate	72	28
Furosemide	Furosemide	70	31
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	69	16
Allopurinol	Allopurinol	67	16
Ezetimibe	Ezetimibe	64	17
Hydroxyzine Hcl	Hydroxyzine Hcl	64	25
Clopidogrel	Clopidogrel Bisulfate	62	22
Pravastatin Sodium	Pravastatin Sodium	62	21
Simvastatin	Simvastatin	61	18
Zolpidem Tartrate	Zolpidem Tartrate	61	12
Citalopram Hbr	Citalopram Hydrobromide	59	22
Esomeprazole Magnesium	Esomeprazole Magnesium	57	suppressed
Nifedipine Er	Nifedipine	53	14
Famotidine	Famotidine	50	20
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	48	22
Alendronate Sodium	Alendronate Sodium	46	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	46	13
Glipizide	Glipizide	45	15
Lovastatin	Lovastatin	45	16
Carvedilol	Carvedilol	44	12
Escitalopram Oxalate	Escitalopram Oxalate	44	19
Potassium Chloride	Potassium Chloride	44	18
Atenolol	Atenolol	42	14
Baclofen	Baclofen	42	19
Fluticasone Propionate	Fluticasone Propionate	40	21
Meloxicam	Meloxicam	39	14
Eliquis	Apixaban	37	11
Jardiance	Empagliflozin	36	suppressed
Buspirone Hcl	Buspirone Hcl	35	12
Ibuprofen	Ibuprofen	35	12
Farxiga	Dapagliflozin Propanediol	34	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	12
Mounjaro	Tirzepatide	34	suppressed
Celecoxib	Celecoxib	32	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	32	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	32	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	32	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	13
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Breo Ellipta	Fluticasone/Vilanterol	29	suppressed
Gemfibrozil	Gemfibrozil	29	suppressed
Sertraline Hcl	Sertraline Hcl	29	13
Pregabalin	Pregabalin	28	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	suppressed
Mirtazapine	Mirtazapine	26	11
Tizanidine Hcl	Tizanidine Hcl	25	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	24	suppressed
Diclofenac Sodium	Diclofenac Sodium	23	suppressed
Linzess	Linaclotide	22	suppressed
Metformin Hcl Er	Metformin Hcl	22	suppressed
Prednisone	Prednisone	22	20
Xarelto	Rivaroxaban	22	suppressed
Bupropion Xl	Bupropion Hcl	21	suppressed
Glipizide Er	Glipizide	21	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Chlorthalidone	Chlorthalidone	19	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	18	suppressed
Finasteride	Finasteride	18	suppressed
Lorazepam	Lorazepam	18	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	suppressed
Amoxicillin	Amoxicillin	16	16
Benazepril Hcl	Benazepril Hcl	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Azithromycin	Azithromycin	15	15
Fluconazole	Fluconazole	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Doxepin Hcl	Doxepin Hcl	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Torsemide	Torsemide	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Alprazolam	Alprazolam	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Cephalexin	Cephalexin	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Enalapril-Hydrochlorothiazide	Enalapril/Hydrochlorothiazide	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Spironolactone	Spironolactone	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error